299 related articles for article (PubMed ID: 28465043)
1. Impact of age and cytomegalovirus on CD8
Cantisán S; Páez-Vega A; Santos F; Rodríguez-Benot A; Aguado R; Rivero A; Montejo M; Torre-Cisneros J; Solana R;
Exp Gerontol; 2017 Sep; 95():98-106. PubMed ID: 28465043
[TBL] [Abstract][Full Text] [Related]
2. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
3. Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG+ response.
Páez-Vega A; Poyato A; Rodriguez-Benot A; Guirado L; Fortún J; Len O; Abdala E; Fariñas MC; Cordero E; de Gracia C; Hernández D; González R; Torre-Cisneros J; Cantisán S; ;
Antiviral Res; 2018 Jul; 155():97-105. PubMed ID: 29782877
[TBL] [Abstract][Full Text] [Related]
4. Prevention strategies differentially modulate the impact of cytomegalovirus replication on CD8(+) T-cell differentiation in high-risk solid organ transplant patients.
Cantisán S; Páez-Vega A; Pérez-Romero P; Montejo M; Cordero E; Gracia-Ahufinger I; Martín-Gandul C; Maruri N; Aguado R; Solana R; Torre-Cisneros J;
Antiviral Res; 2016 Aug; 132():244-51. PubMed ID: 27378225
[TBL] [Abstract][Full Text] [Related]
5. Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.
López-Oliva MO; Martinez V; Buitrago A; Jiménez C; Rivas B; Escuin F; Santana MJ; Selgas R; Bellón T
Transplantation; 2014 Apr; 97(8):839-45. PubMed ID: 24345896
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.
Cantisán S; Torre-Cisneros J; Lara R; Rodríguez-Benot A; Santos F; Gutiérrez-Aroca J; Gayoso I; González-Padilla M; Casal M; Rivero A; Solana R
Clin Vaccine Immunol; 2009 Oct; 16(10):1429-38. PubMed ID: 19656991
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant interferon-γ secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation.
Cantisán S; Lara R; Montejo M; Redel J; Rodríguez-Benot A; Gutiérrez-Aroca J; González-Padilla M; Bueno L; Rivero A; Solana R; Torre-Cisneros J
Am J Transplant; 2013 Mar; 13(3):738-45. PubMed ID: 23311355
[TBL] [Abstract][Full Text] [Related]
8. Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study.
Di Benedetto S; Derhovanessian E; Steinhagen-Thiessen E; Goldeck D; Müller L; Pawelec G
Biogerontology; 2015 Oct; 16(5):631-43. PubMed ID: 25732234
[TBL] [Abstract][Full Text] [Related]
9. Specific Immunity to Cytomegalovirus in Pediatric Cardiac Transplantation.
Jacobsen MC; Manunta MDI; Pincott ES; Fenton M; Simpson GL; Klein NJ; Burch M
Transplantation; 2018 Sep; 102(9):1569-1575. PubMed ID: 29509573
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
Cummins NW; Deziel PJ; Abraham RS; Razonable RR
Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
[TBL] [Abstract][Full Text] [Related]
11. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
[TBL] [Abstract][Full Text] [Related]
12. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
Lochmanova A; Lochman I; Tomaskova H; Marsalkova P; Raszka J; Mrazek J; Dedochova J; Martinek A; Brozmanova H; Grundmann M
Transplant Proc; 2010 Nov; 42(9):3574-7. PubMed ID: 21094818
[TBL] [Abstract][Full Text] [Related]
13. CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy.
Mena-Romo JD; Pérez Romero P; Martín-Gandul C; Gentil MÁ; Suárez-Artacho G; Lage E; Sánchez M; Cordero E
J Infect; 2017 Oct; 75(4):336-345. PubMed ID: 28599954
[TBL] [Abstract][Full Text] [Related]
14. Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study.
Molina-Ortega A; Martín-Gandul C; Mena-Romo JD; Rodríguez-Hernández MJ; Suñer M; Bernal C; Sánchez M; Sánchez-Céspedes J; Pérez Romero P; Cordero E
Clin Microbiol Infect; 2019 Jun; 25(6):753-758. PubMed ID: 30292792
[TBL] [Abstract][Full Text] [Related]
15. Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+ T-cell reconstitution in pediatric hematopoietic stem cell transplant patients.
Paouri B; Soldatou A; Petrakou E; Theodosaki M; Tsentidis C; Kaisari K; Oikonomopoulou C; Matsas M; Goussetis E
Pediatr Transplant; 2018 Aug; 22(5):e13220. PubMed ID: 29777573
[TBL] [Abstract][Full Text] [Related]
16. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers.
Gamadia LE; Rentenaar RJ; Baars PA; Remmerswaal EB; Surachno S; Weel JF; Toebes M; Schumacher TN; ten Berge IJ; van Lier RA
Blood; 2001 Aug; 98(3):754-61. PubMed ID: 11468176
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.
Castón JJ; Cantisán S; González-Gasca F; Páez-Vega A; Abdel-Hadi H; Illescas S; Alonso G; Torre-Cisneros J
Intensive Care Med; 2016 Jan; 42(1):46-53. PubMed ID: 26537489
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults.
Riddell NE; Griffiths SJ; Rivino L; King DC; Teo GH; Henson SM; Cantisan S; Solana R; Kemeny DM; MacAry PA; Larbi A; Akbar AN
Immunology; 2015 Apr; 144(4):549-60. PubMed ID: 25314332
[TBL] [Abstract][Full Text] [Related]
20. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells.
Vescovini R; Telera A; Fagnoni FF; Biasini C; Medici MC; Valcavi P; di Pede P; Lucchini G; Zanlari L; Passeri G; Zanni F; Chezzi C; Franceschi C; Sansoni P
Exp Gerontol; 2004 Aug; 39(8):1233-43. PubMed ID: 15288697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]